Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb;12(2):725-34.
doi: 10.1002/j.1460-2075.1993.tb05706.x.

Human anti-self antibodies with high specificity from phage display libraries

Affiliations

Human anti-self antibodies with high specificity from phage display libraries

A D Griffiths et al. EMBO J. 1993 Feb.

Abstract

Recently we demonstrated that human antibody fragments with binding activities against foreign antigens can be isolated from repertoires of rearranged V-genes derived from the mRNA of peripheral blood lymphocytes (PBLs) from unimmunized humans. The heavy and light chain V-genes were shuffled at random and cloned for display as single-chain Fv (scFv) fragments on the surface of filamentous phage, and the fragments selected by binding of the phage to antigen. Here we show that from the same phage library we can make scFv fragments encoded by both unmutated and mutated V-genes, with high specificities of binding to human self-antigens. Several of the affinity purified scFv fragments were shown to be a mixture of monomers and dimers in solution by FPLC gel filtration and the binding kinetics of the dimers were determined using surface plasmon resonance (k(on) = 10(5)-10(6) M-1s-1, k(off) = 10(-2)s-1 and Ka = 10(7) M-1). The kinetics of association are typical of known Ab-protein interactions, but the kinetics of dissociation are relatively fast. For therapeutic application, the binding affinities of such antibodies could be improved in vitro by mutation and selection for slower dissociation kinetics.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biotechnology (N Y). 1992 Jul;10(7):779-83 - PubMed
    1. Eur J Immunol. 1992 Jul;22(7):1719-28 - PubMed
    1. J Biol Chem. 1992 Aug 15;267(23):16007-10 - PubMed
    1. Mol Immunol. 1992 Sep;29(9):1031-42 - PubMed
    1. J Mol Biol. 1992 Oct 5;227(3):776-98 - PubMed

Publication types

Associated data